Ghent University Academic Bibliography

Journal Article
A1
open access

Chemotherapy-treated breast cancer cells activate the WNT signaling pathway to enter a diapause-like early persister state

Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba, Alessandra Qualizza, Gwenny Cosemans (UGent) , Paula Garcia-Diaz, François Richard, Paraskevi Athanasouli, Carla Rios Luci, Wout De Wispelaere, et al.

(2026) CANCER RESEARCH. 86(2). p.310-330

Add to list

Miscellaneous

Launching SMART 3D cancer models

Sam Ernst (UGent) and Olivier De Wever (UGent)

(2025) CANCER RESEARCH. 85(9). p.1568-1570

Add to list

Conference Paper

Distinct mechanisms of CD28 and 4-1BB costimulation in glofitamab combination therapies for relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Koorosh Korfi, Zhiwen Jiang, Sabine Wilson, Ailsa Christiansen, Wilfred Leung, Katharina Lechner, Natalie Dimier, Philip Knuckles, Kat Reyskens, Iva Lelios, et al.

(2025) CANCER RESEARCH. 85(8).

Add to list

Journal Article
A1
open access

Depleting IL1R2+ tumor-infiltrating regulatory T cells with an ADCC-prone nanobody construct boosts the efficacy of anti-PD-1 immunotherapy

Sana M. Arnouk, Daliya Kancheva, Helena Van Damme, Guillaume E. Courtoy, Romina Mora Barthelmess, Jolien Van Craenenbroeck, Els Lebegge, Yvon Elkrim, Naela Assaf, Yves Heremans, et al.

(2025) CANCER RESEARCH. 85(23). p.4681-4700

Add to list

AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia

Niels Vandewalle, Hatice Satilmis, Emma M. Verheye, Rong Fan, Yanmeng Wang, Timo W. De Groof, Tessa Kerre (UGent) , Nathan De Beule, Ann De Becker, Elke De Bruyne, et al.

(2024) CANCER RESEARCH. In Cancer Research 84(6, Supplement S).

Add to list

GRACE-trial : a randomized active-controlled trial for vulvovaginal atrophy in breast cancer patients on endocrine therapy

Glenn Vergauwen (UGent) , Piet Cools (UGent) , Hannelore Denys (UGent) , Tom Fiers (UGent) , Koen Van de Vijver (UGent) , Liv Veldeman (UGent) and Hans Verstraelen (UGent)

(2024) CANCER RESEARCH. In Cancer Research 84(9, Supplement S).

Add to list

Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer

Jonathan Chou, Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M. Robinson, et al.

(2023) CANCER RESEARCH. 83(2). p.301-315

Add to list

Conference Paper
C3
open access

A first-in-human, open-label, multicenter study of intratumoral SAR441000 (mixture of cytokine encoding mRNAs), as monotherapy and in combination with cemiplimab in patients with advanced solid tumors

Oliver Bechter, Carmen Loquai, Stephane Champiat, Jean Francois Baurain, Jean-Jacques Grob, Jochen Utikal, Sylvie Rottey (UGent) , Alfonso Berrocal, Jessica Hassel, Ana Arance, et al.

(2023) CANCER RESEARCH. In Cancer Research 83(8, Supplement S).

Add to list

Conference Paper
C3
open access

A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumors

Nuria Kotecki, Sylvie Rottey (UGent) , Elena Garralda, Maria de de Miguel, Omar Saavedra, Valentina Boni, Judit W. Johnson, Jonathan P. McNally, Mohit Mathew, Adam Hughes, et al.

(2023) CANCER RESEARCH. In Cancer Research 83(8, Supplement S).

Add to list

Abstract LB272: Spatial cellular architecture predicts prognosis in glioblastoma

Yuanning Zheng, Francisco Carrillo-Perez, Marija Pizurica (UGent) and Olivier Gevaert

(2023) CANCER RESEARCH. 83(8).

Academic Bibliography

Chemotherapy-treated breast cancer cells activate the WNT signaling pathway to enter a diapause-like early persister state

Launching SMART 3D cancer models

Distinct mechanisms of CD28 and 4-1BB costimulation in glofitamab combination therapies for relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Depleting IL1R2+ tumor-infiltrating regulatory T cells with an ADCC-prone nanobody construct boosts the efficacy of anti-PD-1 immunotherapy

AXL-specific single domain antibodies show diagnostic potential and antitumor activity in acute myeloid leukemia

GRACE-trial : a randomized active-controlled trial for vulvovaginal atrophy in breast cancer patients on endocrine therapy

Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer

A first-in-human, open-label, multicenter study of intratumoral SAR441000 (mixture of cytokine encoding mRNAs), as monotherapy and in combination with cemiplimab in patients with advanced solid tumors

A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumors

Abstract LB272: Spatial cellular architecture predicts prognosis in glioblastoma

Contents

Support

Contact